The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about…
Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved…
Last month, I highlighted some of the most impactful, talked-about, or interesting articles published across the spectrum…
The blood thinning effects of dabigatran (Pradaxa) can be quickly and reliably reversed by giving idarucizumab (Praxbind)…
Much has changed in the realm of oral anticoagulation over the past few years. Beginning with the…